期刊文献+

早期应用低蛋白加α酮酸饮食对延缓KK-Ay小鼠糖尿病肾病进展的作用 被引量:1

Slowing Progression of Diabetic Nephropathy in KK-Ay Mice by Early Using Low Protein Diet Associate with α-ketose
下载PDF
导出
摘要 目的:观察早期应用低蛋白加α酮酸饮食对2型糖尿病肾病动物模型KK-Ay小鼠肾脏病变的影响,并探讨其作用机制。方法:雄性KK-Ay小鼠30只,12周龄开始给予不同饮食干预,分为正常蛋白组(22%酪蛋白,NPD组)15只和低蛋白加α酮酸组(5%酪蛋白+1%α酮酸,Keto组)15只;另设性别周龄相同的C57/BL6J小鼠15只为对照(CON组),始终给予正常蛋白饮食。检测第8、14、20周龄各组小鼠尿白蛋白,血清中葡萄糖、胰岛素、糖化血红蛋白、胆固醇、三酰甘油、尿素氮、肌酐、白蛋白等生化变化。对20周龄小鼠肾组织病理进行图文分析和半定量检测,免疫组化方法测定肾组织中TGF-β、FN表达量。结果:Keto组小鼠14周龄时血糖、ACR(白蛋白/肌酐)、尿白蛋白排泄率、三酰甘油低于NPD组(P<0.05),20周龄时糖化血红蛋白、血胰岛素、肾小球面积及系膜区面积显著降低(P<0.05)。免疫组化结果显示NPD组小鼠肾内TGF-β蛋白表达及肾小球FN沉积明显增多(P<0.05)。结论:早期应用低蛋白加α酮酸饮食能够显著降低KK-Ay小鼠尿白蛋白,减轻系膜基质增生和结节性硬化,而不引起营养不良,并可能通过减少TGF-β表达抑制FN等系膜基质增加而延缓糖尿病肾病的进展。 Objective:To evaluate the effects of early low protein diet (LPD)supplemented with α- keto acid on diabetic nephropathy of type 2 diabetes mellitus in KK -Ay mice,and to elucidate the mechanisms involved. Methods:30 male 12 - weekage KK - Ay mice were divided into two groups,normal protein diet group(22 % casein diet, n = 15) and LPD+α - keto group (5% casein + 1%a - keto, n = 15). 15 sex - and - age matched C57/BL6J mice were served as the control group. Urine album,serum glucose, insulin, lipids, albumin, creatinine and urea nitrogen were measured at the age of 8,14 and 20 weeks. Renal tissue was observed to assess pathologic change. Immunohistochemistry method was used to evaluate the extent of expression of TGF - β and FN. Re- suits:The levels of urine album, serum glucose, triglyceride in LPD + α- keto group were significantly lower than that in NPD group after 14 weeks (P〈 0.05). There were significant differences in glycosylated hemoglobin, insulin and area of mesangial region after treated than before at groups NPD and keto (P〈0.05). Expressions of TGF- β and FN were also lower in keto group (P〈0.05). Conclusion: LPD supplemented with α - keto acid can protect early diabetic kidney from malnutrition and aggravation of metabolic disturbance. Keto acid may ameliorate the renal fibrosis by reducing the expressions of TGF- β and FN.
出处 《中国中西医结合肾病杂志》 2009年第8期674-677,I0002,共5页 Chinese Journal of Integrated Traditional and Western Nephrology
基金 上海市科学技术委员会重大项目(No.08D21900600)
关键词 限制蛋白质 酮酸类 2型糖尿病 糖尿病肾病 肾间质纤维化 Protein- restricted Ketoacids Type 2 diabetes mellitus Diabetic nephropathy Renal interstitial fibrosis
  • 相关文献

参考文献10

  • 1Hagiwara S, Makita Y, Gu L, et al. Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP- 1 suppression and decreased ERK1/2 and p38 phosphorylation. Nephrol Dial Transplant, 2006,21 (3) : 605 - 615.
  • 2陈伟,向红丁,于康,马方.限蛋白质摄入对2型糖尿病早期肾病的影响[J].中国糖尿病杂志,2000,8(4):207-209. 被引量:58
  • 3Feiten SF, Draibe SA, Watanabe R, et al. Short - term effects of a very- low- protein diet supplemented with ketoacids in nondialyzed chronic kidney disease patients. Eur J Clin Nutr, 2005, 59(1 ) : 129 - 136.
  • 4Eyre S,Attman PO, Haraldsson B. Positive effects of protein restriction in patients with chronic kidney disease. J Ren Nutr, 2008,18(3) :269 - 280.
  • 5Nishitani S, Ijichi C, Takehana K, et al. Pharmacoloical activities of branchedchain amino acid: specificity of tissue and signal transduction. Biochem Biophys Res Commun, 2004,313 (2) : 387 - 389.
  • 6刘秋菊,李英.脂代谢紊乱与糖尿病肾病[J].中国中西医结合肾病杂志,2002,3(11):682-684. 被引量:4
  • 7Teplan V, Schuck O, Votruba M, et al. Metabolic effects of keto acid - amino acid supplementation in patients with chronic renal insufficiency receiving a low - protein diet and recombinant human erythropoietin - a randomized controlled trail. Wien Klin Wochenschr,2001,113( 17 - 18) :661 - 669.
  • 8Monzani G, Bergesio F, Ciuti R, et al. LP(a) levels: effects of progressive cronic renal failure and dietary management. J Nephrol, 1997,10(1) :41 - 45.
  • 9宋立群,施海涛.浅谈糖尿病肾病合并脂代谢紊乱的防治策略[J].中国中西医结合肾病杂志,2008,9(3):279-280. 被引量:4
  • 10董哲毅,华参,高翔,华振浩,吉程程,熊锡山,胡惠民,梅长林.2型糖尿病动物模型KK-Ay小鼠糖尿病肾病的鉴定[J].山东医药,2008,48(13):17-19. 被引量:9

二级参考文献38

  • 1刘振平,潘长玉.低蛋白饮食与糖尿病肾病[J].国外医学(内科学分册),1993,20(8):351-352. 被引量:8
  • 2叶山东,胡远峰.限制蛋白质摄入对糖尿病肾病的作用[J].上海医学,1993,16(4):243-245. 被引量:4
  • 3梁兴伦,韩明向.X综合征中医药治疗探讨[J].安徽中医临床杂志,1995,7(1):59-60. 被引量:14
  • 4Abate N, Vega GL, Garg A, et al. Abnormal cholesterol distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM. Atherosclerosis, 1995,118(1):111 - 122.
  • 5Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferator- activated receptor (PPAR)in mediation the effects of fibratesand fatty acids on gene expression. J Lipid Res, 1996,37:907 - 925.
  • 6Kamanna VS, Bassa BV, Kirschenbaum MA. Atherogenic lipoproteins and human disease: extending concepts beyond the heart to the kidney. Curr Opin Nephrol Hypertens,1997,6(3) :205 - 211.
  • 7Gyone EF, Walli AK, Gyone HJ, et al. The role of lipids in nephrosis and glomerulosclerosis. Atherosclerosis, 1994, 107(1):1-13.
  • 8Horie K, Miyata T, Maeda K, et al. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest, 1997,100(12) :2995 - 3004.
  • 9Soedamah-Muthu SS, Colhoun HM, Taskinen MR,et al.Differences in HDL - cholesterol: apoA - Ⅰ + apoA - Ⅱratio and apoE phenotype with albuminuric status in Type Ⅰ diabetic patients. Diabetologia,2000, 43 (11): 1353 -1359.
  • 10Hirano T, Oi K, Sakai S, et al. High prevalence of small dense LDL in diabetic nephropathy is not directly associated with kidney damage: a possible role of postprandial lipemia.Atherosclerosis, 1998,141 (1): 77 - 85.

共引文献70

同被引文献34

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部